Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Reading LevelReading Level
-
Content TypeContent Type
-
YearFrom:-To:
-
More FiltersMore FiltersItem TypeIs Full-Text AvailableSubjectPublisherSourceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
6
result(s) for
"Sahay, Raj R"
Sort by:
Inside the Indian business mind : a tactical guide for managers
by
Zubko, Katherine C.
,
Sahay, Raj R.
in
Business enterprises
,
Business enterprises -- India
,
Business etiquette
2010
This practical guide identifies the ingredients that make up Indian culture and uniquely translates them into useful tools to help Western commercial initiatives succeed. There is enormous opportunity for companies that want to sell to India's one billion consumers or partner with Indian companies, but doing so isn't always easy. Inside the Indian Business Mind: A Tactical Guide for Managers offers a primer on the culture and its opportunities. This unique guide will help Western business people enter the Indian market, make the best use of Indian manufacturing facilities, and create and develop successful, long-term business relationships with Indian business partners and teams. The book is not a list of dos and don'ts. Rather, it approaches doing business in India from the perspective of in-depth cultural models, translating cultural knowledge into practical working strategies. The authors, an Indian who has worked in the United States and an American who has worked in India, arm readers with an understanding of 11 primary cultural ingredients that come into play in business relationships with South Asians—ingredients that can be mastered and adapted across many contexts to forge lucrative partnerships.
Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India
by
Gawande, Pranita
,
Shukla, Aishwarya
,
Singh, Ravi Shankar
in
COVID-19
,
COVID-19 vaccines
,
Curfews
2022
BackgroundRecent studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reveal that Omicron variant BA.1 and sub-lineages have revived the concern over resistance to antiviral drugs and vaccine-induced immunity. The present study aims to analyze the clinical profile and genome characterization of the SARS-CoV-2 variant in eastern Uttar Pradesh (UP), North India.MethodsWhole-genome sequencing (WGS) was conducted for 146 SARS-CoV-2 samples obtained from individuals who tested coronavirus disease 2019 (COVID-19) positive between the period of 1 January 2022 and 24 February 2022, from three districts of eastern UP. The details regarding clinical and hospitalized status were captured through telephonic interviews after obtaining verbal informed consent. A maximum-likelihood phylogenetic tree was created for evolutionary analysis using MEGA7.ResultsThe mean age of study participants was 33.9 ± 13.1 years, with 73.5% accounting for male patients. Of the 98 cases contacted by telephone, 30 (30.6%) had a travel history (domestic/international), 16 (16.3%) reported having been infected with COVID-19 in past, 79 (80.6%) had symptoms, and seven had at least one comorbidity. Most of the sequences belonged to the Omicron variant, with BA.1 (6.2%), BA.1.1 (2.7%), BA.1.1.1 (0.7%), BA.1.1.7 (5.5%), BA.1.17.2 (0.7%), BA.1.18 (0.7%), BA.2 (30.8%), BA.2.10 (50.7%), BA.2.12 (0.7%), and B.1.617.2 (1.3%) lineages. BA.1 and BA.1.1 strains possess signature spike mutations S:A67V, S:T95I, S:R346K, S:S371L, S:G446S, S:G496S, S:T547K, S:N856K, and S:L981F, and BA.2 contains S:V213G, S:T376A, and S:D405N. Notably, ins214EPE (S1- N-Terminal domain) mutation was found in a significant number of Omicron BA.1 and sub-lineages. The overall Omicron BA.2 lineage was observed in 79.5% of women and 83.2% of men.ConclusionThe current study showed a predominance of the Omicron BA.2 variant outcompeting the BA.1 over a period in eastern UP. Most of the cases had a breakthrough infection following the recommended two doses of vaccine with four in five cases being symptomatic. There is a need to further explore the immune evasion properties of the Omicron variant.
Journal Article